185 related articles for article (PubMed ID: 17852716)
21. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
22. Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.
Kaldau NC; Brorson S; Jensen PE; Schultz C; Arpi M
Int J Infect Dis; 2012 Jan; 16(1):e16-22. PubMed ID: 22129759
[TBL] [Abstract][Full Text] [Related]
23. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex.
Cone LA; Byrd RG; Potts BE; Wuesthoff M
Surg Neurol; 2004 Sep; 62(3):234-7; discussion 237. PubMed ID: 15336867
[TBL] [Abstract][Full Text] [Related]
26. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
27. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.
Hsu DI; Nguyen M; Nguyen L; Law A; Wong-Beringer A
J Antimicrob Chemother; 2010 Aug; 65(8):1765-70. PubMed ID: 20554567
[TBL] [Abstract][Full Text] [Related]
28. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
Gubler C; Wildi SM; Imhof A; Schneemann M; Müllhaupt B
Infection; 2007 Oct; 35(5):364-6. PubMed ID: 17721739
[TBL] [Abstract][Full Text] [Related]
29. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
30. Infections caused by Candida krusei in five transplant and two surgical patients.
Bonatti H; Stelzmueller I; Berger N; Lechner M; Grif K; Geltner C; Margreiter R; Lass-Flörl C
Surg Infect (Larchmt); 2009 Jun; 10(3):265-71. PubMed ID: 19485782
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine.
Dumaine V; Eyrolle L; Baixench MT; Paugam A; Larousserie F; Padoin C; Tod M; Salmon D
Int J Antimicrob Agents; 2008 Apr; 31(4):398-9. PubMed ID: 18242959
[No Abstract] [Full Text] [Related]
32. Neonatal liver abscesses due to Candida infection effectively treated with caspofungin.
Filippi L; Poggi C; Gozzini E; Meleleo R; Mirabile L; Fiorini P
Acta Paediatr; 2009 May; 98(5):906-9. PubMed ID: 19187395
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical effect to caspofungin in Candida species does not confer survival advantage in a Drosophila model of candidiasis.
Zanette RA; Kontoyiannis DP
Virulence; 2013 Aug; 4(6):497-8. PubMed ID: 23863608
[No Abstract] [Full Text] [Related]
34. Refractory candidal meningitis in an immunocompromised patient cured by caspofungin.
Liu KH; Wu CJ; Chou CH; Lee HC; Lee NY; Hung ST; Ko WC
J Clin Microbiol; 2004 Dec; 42(12):5950-3. PubMed ID: 15583351
[TBL] [Abstract][Full Text] [Related]
35. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
Jiménez-Expósito MJ; Torres G; Baraldés A; Benito N; Marco F; Paré JC; Moreno A; Claramonte X; Mestres CA; Almela M; García de la María C; Pérez N; Schell WA; Corey GR; Perfect J; Jiménez de Anta MT; Gatell JM; Miró JM
Clin Infect Dis; 2004 Oct; 39(7):e70-3. PubMed ID: 15472836
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient.
Etienne A; Datry A; Gaspar N; Morel V; Delabesse E; Lmimouni B; Vernant JP; Dhédin N
Mycoses; 2008 May; 51(3):270-2. PubMed ID: 18399909
[TBL] [Abstract][Full Text] [Related]
37. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
38. Candida osteomyelitis and disc space infection of the lumbar spine.
Munk PL; Lee MJ; Poon PY; O'Connell JX; Coupland DB; Janzen DL; Logan PM; Dvorak MF
Skeletal Radiol; 1997 Jan; 26(1):42-6. PubMed ID: 9040142
[TBL] [Abstract][Full Text] [Related]
39. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Mariné M; Pastor FJ; Serena C; Guarro J
Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
